Dallas Fort Worth Injury Lawyer Blog

November 19, 2013

Smith and Nephew Birmingham Hip and R3 Acetabular Lawsuits

There has been many warnings issued to health departments world wide about potential problems with Smith & Nephew’s Birmingham metal-on-metal hip replacements. These hip model and others including the R3 model, have been linked to a high failure rate according to implant registry data in Europe and Australia.

Smith & Nephew recently issued a safety notice that indicates the Birmingham hip failure rate appears to be higher than 1%, which exceeds the rate established for quality standards according to the United Kingdom’s National Institute for Health and Clinical Excellence.

According to data collected since 2010 in the National Joint Registry of England and Wales, as well as the Australian Orthopaedic Associations National Joint Replacement Registry, the rate of Smith & Nephew Birmingham hip problems that were classified as a failure were 1.29% and 1.12%, respectively.

November 19, 2013

Johnson and Johnson DePuy ASR Finalized Settlement Explained

by Dr. Shezad Malik

Today in open federal court in Toledo, Ohio, Johnson & Johnson agreed to pay at least $2.47 billion to settle thousands of lawsuits over its recalled hip implants. The agreement would settle about 8,000 U.S. suits against J&J’s DePuy unit brought by patients who have already had artificial hips removed. The company will pay an average of about $250,000 for each surgery and cover related medical costs.

Johnson & Johnson Under Fire from Lawsuits

The settlement is the second multibillion-dollar settlement this month for J&J. The company, agreed November 4 to pay $2.2 billion to resolve criminal and civil probes into the marketing of Risperdal and other medicines.

November 16, 2013

Dr Shezad Malik Explains Johnson and Johnson DePuy ASR Hip Implant Settlement

by Dr. Shezad Malik

For the folks who have been injured or severely maimed by the defective Depuy ASR metal on metal hip implant, relief is around the corner. According to unnamed sources, Bloomberg News and the New York Times, a mammoth settlement is pending release in open federal court on Tuesday November 19th.

The proposed settlement is going to be presented in federal court and will need the blessing of the federal judge overseeing the DePuy ASR litigation, which at last count has passed the 12,000 mark for folks afflicted by the allegedly faulty hip implant.

November 13, 2013

$4 Billion J&J DePuy Settles ASR Metal Hip Lawsuits

by Dr. Shezad Malik

According to Bloomberg News, Johnson & Johnson (JNJ) will pay more than $4 billion to resolve the product liability lawsuits over its recalled hip implants. This massive settlement is the largest of U.S. lawsuit claims over an allegedly defective medical device, and affects thousands of patients who have been injured by the metal on metal hip implant.

Settlement Impacts Thousands of Patients

November 10, 2013

Bard IVC Filter Injuries, Recovery and G2 in the news

by Dr. Shezad Malik

Our law firm recently filed a product liability lawsuit against C.R. Bard, which claims that one of the company’s IVC (inferior vena cava, is a major vein that runs the length of the body from the heart down to the leg) filters failed. The Bard IVC filter has cut into the walls of the woman’s vena cava and it cannot be removed without major invasive surgery.

Robin Arnold and her husband, Felix, filed her case in the U.S. District Court for the Western District of Texas. They filed claims against Bard for negligence, failure to warn, design defects, manufacturing defects, breach of implied warranty, negligent misrepresentation and loss of consortium.

November 10, 2013

Actos Bladder Cancer Lawsuit Update

by Dr. Shezad Malik

According to a Maryland jury, Takeda Pharmaceutical Co. failed to properly warn about the risks of its Actos diabetes drug and ordered the company to pay more than $1.7 million in damages. This was the second state court Actos bladder case injury case to go to trial. The judge overseeing the case immediately threw out the verdict.

Actos Bladder Cancer: The Jury Speaks

November 9, 2013

Bayer has Settled $1.6 Billion Yaz and Yasmin Blood Clot Lawsuits

by Dr. Shezad Malik

According to Bayer, the pharmaceutical giant has paid out more than $1.6 billion in settlements over Yasmin and Yaz blood clot embolism injuries. The German drug manufacturer is exposed to thousands of product liability drug claims that allege that women suffered severe blood clots due to dangerous side effects of the birth control pills. Bayer has been settling these injury cases over the past 2 years.

Bayer 3rd Quarter Report

November 8, 2013

Fresenius Granuflo and Naturalyte Lawsuit Update

by Dr. Shezad Malik

Granuflo and Naturalyte Dialysate Lawsuits are progressing slowly in the consolidated federal court action, centered in Massachusetts. The federal court is overseeing the multidistrict litigation that has been established for claims that dialysis patients suffered sudden heart problems from Granuflo or Naturalyte.

More than 300 Lawsuits in Federal MDL

November 4, 2013

Stryker Rejuvenate Hip Implants Ordered to Mediation

by Dr. Shezad Malik

Stryker Rejuvenate hip lawsuits are on a fast track in New Jersey state court, with a court mandated mediation program in place to try and reach a settlement.

More than 430 defective hip product liability Stryker Rejuvenate and ABG II hip stems lawsuits are centralized in the Superior Court for Bergen County, New Jersey before Judge Brian R. Martinotti.

October 4, 2013

DePuy ASR Hip Failure Lawsuits Heading to Settlement?

by Dr. Shezad Malik

There is media speculation that Johnson & Johnson (J&J), and its subsidiary DePuy, are in active discussions to attempt a global settlement of their defective ASR metal on metal artificial hips.

J&J Potential Settlement North of $3 Billion

Apparently J&J has discussed paying more than $3 billion to settle lawsuits over its recalled hip implants. J&J is exposed to over 11,500 product liability lawsuits in the U.S. and is considering paying more than $300,000 per case.